BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22008899)

  • 1. Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders.
    Krymchantowski AV; da Cunha Jevoux C; Bigal ME
    J Headache Pain; 2012 Jan; 13(1):53-9. PubMed ID: 22008899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine.
    Silberstein SD; Dodick DW; Lindblad AS; Holroyd K; Harrington M; Mathew NT; Hirtz D;
    Neurology; 2012 Mar; 78(13):976-84. PubMed ID: 22377815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate for migraine prevention: a randomized controlled trial.
    Brandes JL; Saper JR; Diamond M; Couch JR; Lewis DW; Schmitt J; Neto W; Schwabe S; Jacobs D;
    JAMA; 2004 Feb; 291(8):965-73. PubMed ID: 14982912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controlled trial.
    Chowdhury D; Mundra A; Datta D; Duggal A; Krishnan A; Koul A
    Cephalalgia; 2022 Aug; 42(9):859-871. PubMed ID: 35259978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polytherapy for migraine prophylaxis.
    Casucci G; Villani V; Cologno D; D'Onofrio F
    Neurol Sci; 2012 May; 33 Suppl 1():S147-50. PubMed ID: 22644191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J;
    Headache; 2005; 45(10):1304-12. PubMed ID: 16324162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study.
    Shaygannejad V; Janghorbani M; Ghorbani A; Ashtary F; Zakizade N; Nasr V
    Headache; 2006 Apr; 46(4):642-8. PubMed ID: 16643559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate.
    Mathew NT; Kailasam J; Meadors L
    Headache; 2002 Sep; 42(8):796-803. PubMed ID: 12390644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
    Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine.
    Cady RK; Schreiber CP; Porter JA; Blumenfeld AM; Farmer KU
    Headache; 2011 Jan; 51(1):21-32. PubMed ID: 21070228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine.
    Mei D; Ferraro D; Zelano G; Capuano A; Vollono C; Gabriele C; Di Trapani G
    Clin Neuropharmacol; 2006; 29(5):269-75. PubMed ID: 16960472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate in migraine prevention: a double-blind, placebo-controlled study.
    Storey JR; Calder CS; Hart DE; Potter DL
    Headache; 2001; 41(10):968-75. PubMed ID: 11903524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.
    Mathew NT; Jaffri SF
    Headache; 2009; 49(10):1466-78. PubMed ID: 19912346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
    Lipton RB; Silberstein S; Dodick D; Cady R; Freitag F; Mathew N; Biondi DM; Ascher S; Olson WH; Hulihan J
    Cephalalgia; 2011 Jan; 31(1):18-30. PubMed ID: 20974598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
    Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate vs divalproex sodium in the preventive treatment of migraine: a prospective "real-world" study.
    Krymchantowski AV; Jevoux CC
    Headache; 2011 Apr; 51(4):554-8. PubMed ID: 21457240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of migraine on daily activities: effect of topiramate compared with placebo.
    Silberstein SD; Loder E; Forde G; Papadopoulos G; Fairclough D; Greenberg S
    Curr Med Res Opin; 2006 Jun; 22(6):1021-9. PubMed ID: 16846536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.